Last Posted: Apr 12, 2020
- New ASD prevalence numbers show gaps are closing, but more work is needed
CDC, April 2020 - Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review.
Pall Amalie Hartvig et al. Acta oncologica (Stockholm, Sweden) 2020 Mar 1-6 - Epigenetic Therapeutics for Cardiovascular Disease- Writing, Erasing, Reading, and Maybe Forgetting
J Plutzky, JAMA, March 27, 2020 - Re-evaluating the first-tier status of fragile X testing in neurodevelopmental disorders.
Borch Lauren A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Mar - Genetic counsellors in a multidisciplinary model of clinical genetics and hereditary cancer.
López-Fernández Adrià et al. Medicina clinica 2020 Mar - Perceived utility of biological testing for autism spectrum disorder is associated with child and family functioning.
Yusuf Afiqah et al. Research in developmental disabilities 2020 Feb 100103605 - Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use.
Husson Thomas et al. Translational psychiatry 2020 Feb 10(1) 77 - Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
Aldosary Mazhor et al. Omics : a journal of integrative biology 2020 Feb - Identification of newborns at risk for autism using electronic medical records and machine learning.
Rahman Rayees et al. European psychiatry : the journal of the Association of European Psychiatrists 2020 Feb 63(1) e22 - Towards the automatic detection of social biomarkers in autism spectrum disorder: introducing the simulated interaction task (SIT)
H Drimalla et al, NPJ Digital Medicine, February 27, 2020
.png)
No hay comentarios:
Publicar un comentario